Oncology Care Model

Reimagine Care and CU Innovations Announce Poster Presentation at American Society of Hematology Annual Meeting and Exposition

Retrieved on: 
Monday, December 11, 2023
Managed Care, Mobile, Wireless, Hardware, Telemedicine, Virtual Medicine, Data Management, Oncology, Technology, Medical Devices, Hospitals, Clinical Trials, Nursing, Wearables, Mobile Technology, Health, Research, Oncology Care Model, DNP, ASH, Hematology, RPM, Patient, Multimedia, Haematopoietic system, Hematopoietic stem cell transplantation, University, Cancer, Home, Society, Poster, Triage, Education, Exposition

Reimagine Care, the nation’s leading provider of virtual and in-home cancer care, along with CU Innovations at the University of Colorado Anschutz Medical Campus (CU), a leading research institution committed to fostering innovation and excellence in education and healthcare, are proud to announce a poster presentation at the prestigious 2023 American Society of Hematology (ASH) Annual Meeting and Exposition.

Key Points: 
  • Reimagine Care, the nation’s leading provider of virtual and in-home cancer care, along with CU Innovations at the University of Colorado Anschutz Medical Campus (CU), a leading research institution committed to fostering innovation and excellence in education and healthcare, are proud to announce a poster presentation at the prestigious 2023 American Society of Hematology (ASH) Annual Meeting and Exposition.
  • View the full release here: https://www.businesswire.com/news/home/20231211447739/en/
    Reimagine Care and CU Innovations Announce Poster Presentation at ASH Meeting and Exposition (Photo: Business Wire)
    The annual meeting serves as a premier platform for the exchange of groundbreaking research and advancements in the field of hematology, bringing together healthcare professionals, researchers, and industry leaders from around the world.
  • This year, Reimagine Care and CU are thrilled to be among the contributors, presenting their forward-looking approach to oncology care.
  • Early intervention and treatment are key in improving outcomes but delays from self-assessments may hinder follow-up care.

Integra Connect Establishes the Largest Oncology Provider Footprint in the U.S. through Strategic Focus on Contracting for Value-based, Precision Oncology

Retrieved on: 
Wednesday, October 18, 2023
APM, Health, Medicare, Organization, CMMI, Center for Medicare and Medicaid Innovation, Cropping system, Estate (law), WEST, VBC, OCM, Medicine, Oncology Care Model, Oncology, Pharmaceutical industry, Nursing

WEST PALM BEACH, Fla., Oct. 18, 2023 /PRNewswire/ -- Integra Connect, LLC., a leader in value-based, precision medicine solutions for specialty care, announced that more than 3,800 oncologists from nearly 100 community practices, cancer institutions, and health systems adopted its value-based care (VBC) contracting solutions, in the last 1.5 years. This includes participation in one of the oncology alternative payment models (APMs) administered by the Company.

Key Points: 
  • This includes participation in one of the oncology alternative payment models (APMs) administered by the Company.
  • More providers are moving towards VBC with the aim to drive improvements in the quality of care, the cost of treatment decisions, and the processes that improve overall patient health.
  • Integra Connect's latest oncology APM is with a leading commercial insurer that covers approximately 50 million patient lives nationwide.
  • "This is an exciting milestone for Integra Connect because it reinforces that we are the partner-of-choice for organizations looking to succeed with oncology value-based care," said Raj Mantena, Chairman and Founder of Integra Connect.

The Institute for Value-Based Medicine® from The American Journal of Managed Care® hosts “The Challenges Facing Value-Based Oncology Care in a Postpandemic World” event in Charlotte

Retrieved on: 
Friday, October 13, 2023
American Journal of Bioethics, COVID-19, Ace Hotel, Oncology Care Model, Challenge, American Journal, IVBM, Pharmaceutical industry

This event, "The Challenges Facing Value-Based Oncology Care in a Postpandemic World," will convene health care industry leaders to explore the latest innovations in value-based care and the evolving landscape of a postpandemic world.

Key Points: 
  • This event, "The Challenges Facing Value-Based Oncology Care in a Postpandemic World," will convene health care industry leaders to explore the latest innovations in value-based care and the evolving landscape of a postpandemic world.
  • The COVID-19 pandemic has dramatically reshaped the health care landscape, presenting unique challenges to the delivery of oncology care.
  • IVBM recognizes the pressing need to address these issues and foster discussions that can lead to innovative solutions for value-based oncology care.
  • In addition to the invaluable knowledge exchange, the event will offer attendees a complimentary dinner, fostering networking opportunities in a relaxed setting.

American Oncology Network Announces Participation in the Enhancing Oncology Model

Retrieved on: 
Wednesday, July 26, 2023
Heart, Partnership, Food, Housing, AON, OCM, Oncology Care Model, Health equity, Cancer, EOM, CMMI, Center for Medicare and Medicaid Innovation, Medicare, MD, Patient, Practitioner, Oncology, Transport, Caregiver, Hospital, Nursing

FORT MYERS, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), one of the nation’s fastest-growing networks of community oncology practices, announced its participation in the Enhancing Oncology Model (EOM), a new value-based cancer care framework launched by the Center for Medicare and Medicaid Innovation (CMMI), to improve health outcomes and reduce total costs of care.

Key Points: 
  • FORT MYERS, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), one of the nation’s fastest-growing networks of community oncology practices, announced its participation in the Enhancing Oncology Model (EOM), a new value-based cancer care framework launched by the Center for Medicare and Medicaid Innovation (CMMI), to improve health outcomes and reduce total costs of care.
  • To address the rising costs of cancer and improve care quality, CMMI launched the EOM on July 1st, 2023, a five-year voluntary program for oncology practices.
  • Built on the successes of and lessons learned from its predecessor, the Oncology Care Model (OCM), EOM is indicative of an industry paradigm shift towards value-based cancer care.
  • “Together with AON, we can accelerate EOM to achieve a better patient experience, better outcomes and lower costs of cancer care.”

Duo Health and National Kidney Partners Announce Launch of Statewide Value-based Care Model in Florida

Retrieved on: 
Wednesday, July 26, 2023
Professional Services, Health, Practice Management, Insurance, Other Health, Health Insurance, General Health, Partnership, Chronic kidney disease, Treasure Coast, Quality of life, Multimedia, Oncology Care Model, Kidney disease, Medicare, Kidney, Patient, Standard of care, Nephrology, Physician, Entrepreneurship, ESKD, CKD, Hypertension, Nursing, Pharmaceutical industry, MD, NKP

Duo Health (Duo), a new type of community-based, technology-enabled physician group announced a new partnership in Florida with National Kidney Partners (NKP), a physician-led nephrology organization with care centers across the state.

Key Points: 
  • Duo Health (Duo), a new type of community-based, technology-enabled physician group announced a new partnership in Florida with National Kidney Partners (NKP), a physician-led nephrology organization with care centers across the state.
  • View the full release here: https://www.businesswire.com/news/home/20230726582343/en/
    Duo Health and National Kidney Partners Announce Launch of Statewide Value-based Care Model in Florida (Graphic: Business Wire)
    Duo Health is a value-based medical group purpose-built to support people with chronic kidney disease (CKD) and end-stage kidney disease (ESKD).
  • These care centers include Renal Hypertension Center, Kidney and Hypertension Group of South Florida, Florida Kidney and Hypertension Clinic, Jacksonville Kidney Center, Kidney Institute of Florida, and Kidney Care of the Treasure Coast.
  • “Together with Duo Health, we embark on an exciting journey to expand our programs in value-based care, reaching even more patients in need.

New Healthcare Business Models in Asia-Pacific Making Impacts Post COVID-19

Retrieved on: 
Thursday, July 20, 2023
Single-frequency network, Blockchain, Software as a service, Elderly care, Caregiver, Internet, 3D, COVID-19, Oncology Care Model, Ageing, Digital therapeutics, Machine learning, Medicine, Nanotechnology, Nursing

DUBLIN, July 20, 2023 /PRNewswire/ -- The "Post-pandemic Healthcare Business Models in APAC - 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 20, 2023 /PRNewswire/ -- The "Post-pandemic Healthcare Business Models in APAC - 2023" report has been added to ResearchAndMarkets.com's offering.
  • This study identifies and analyzes the top 10 innovative business models, including home diagnosis, digital therapeutics (DTx), primary care, SaaS models, care models to improve senior care access, de-identified patient data, platforms and marketplaces, care continuum support, comprehensive services for aging in place, and support solutions for caregivers.
  • The COVID-19 pandemic and the shift toward value-based care have highlighted the need for more flexible and resilient healthcare systems, creating opportunities for innovative business models.
  • Growth Drivers: Healthcare Personnel Burnouts & Shortages, Attrition
    Care Models to Improve Senior Care Access: Patina Health
    Comprehensive Services for Aging in Place: ElderAid
    Support Solutions for Caregivers of the Elderly: Vesta Healthcare

Oncology Care Partners Names Dr. Chevon Rariy Chief Health Officer

Retrieved on: 
Thursday, July 13, 2023
Oncology Care Model, Endocrinology, University, Internal medicine, Amazon (company), University of Pittsburgh Medical Center, Quality of life, Research, SVP-24, Government, Harvard Medical School, Cancer Treatment Centers of America, Amazon, Cancer, City, OCP, Publication, Brigham, Digital health, MD, Patient, Op-ed, Machine learning, Artificial intelligence, Hospital, Health, SVP, Brigham and Women's Hospital, Takeda Pharmaceutical Company, Nursing, Medical imaging

NASHVILLE, Tenn., July 13, 2023 /PRNewswire/ -- Oncology Care Partners (OCP), an oncology provider built solely to provide value-based care, today announces the appointment of Chevon Rariy, MD as Chief Health Officer—further elevating its telehealth and digital health capabilities to enhance both patient and provider experience.

Key Points: 
  • NASHVILLE, Tenn., July 13, 2023 /PRNewswire/ -- Oncology Care Partners (OCP), an oncology provider built solely to provide value-based care, today announces the appointment of Chevon Rariy, MD as Chief Health Officer—further elevating its telehealth and digital health capabilities to enhance both patient and provider experience.
  • "I am thrilled to join the dynamic team at OCP, where we are revolutionizing oncology care through a patient-centric value-based approach," said Chevon Rariy, MD.
  • "We are beyond excited to have Dr. Rariy join our senior leadership team," said Erich Mounce, CEO, Oncology Care Partners.
  • With its first two practices across three locations in Phoenix and Miami, Oncology Care Partners is committed to advancing value-based care in oncology nationwide by bringing high-touch, whole-person care that enhances the patient experience across its medical oncology practices.

Lightbeam Health Expands Agreement with Cardinal Health to Advance Enhancing Oncology Model Initiatives

Retrieved on: 
Tuesday, July 11, 2023
Technology, Medical Supplies, Health Technology, Public Policy, Government, Healthcare Reform, Software, General Health, Pharmaceutical, Health, Oncology, Shadow King, Partnership, Doctor of Pharmacy, LCS, OCM, Oncology Care Model, Business, Cardinal, EOM, Experiment (probability theory), Light beam, Research, Social, Cardinal Health, Patient, Axxess Technology Solutions, Artificial intelligence, SVP, Schwind eye tech solutions, Nursing

The Enhancing Oncology Model (EOM) replaced the Oncology Care Model (OCM) in July 2023.

Key Points: 
  • The Enhancing Oncology Model (EOM) replaced the Oncology Care Model (OCM) in July 2023.
  • Through this expanded agreement, Cardinal Health will bolster its EOM offering with Lightbeam’s population health analytics application, Lightbeam Clinical Services (LCS) and Deviceless Remote Patient Monitoring®.
  • “Lightbeam is honored to be Cardinal Health’s trusted partner for population health enablement solutions and capabilities,” says Patrick Burton, SVP of Business Development at Lightbeam Health Solutions.
  • “With its expanded implementation of Lightbeam solutions, Navista™ TS is the all-in-one technology solution for patient-centered oncology care.

Research Presented at ASCO 2023 Shows Implementing Value-Based Care Strategies Such as Dose Rounding Reduces Drug Waste and Total Cost of Care

Retrieved on: 
Monday, June 5, 2023
Science, Practice Management, Research, Pharmaceutical, Oncology, Health, Artificial Intelligence, Technology, Gastrointestinal cancer, NTA, Bevacizumab, BCPS, Elijah Cummings Lower Drug Costs Now Act, Doctor of Pharmacy, Network, MBBS, OCM, Oncology Care Model, Survival, Cancer, EOM, CMMI, Brain, Lung, MS, Colon, ASCO, Center for Medicare and Medicaid Innovation, American Society of Clinical Oncology, Patient, Physician, The Network, Risk, National Television Awards, Improving Medicare Post-Acute Care Transformation Act of 2014, Diagnosis, Society, Medical imaging, Pharmaceutical industry, Nursing, Medicare, MD

Waste from partially used single dose vials of expensive drugs is a leading contributor to avoidable total cost of care (TCOC) expenditures.

Key Points: 
  • Waste from partially used single dose vials of expensive drugs is a leading contributor to avoidable total cost of care (TCOC) expenditures.
  • They found:
    Drug waste led to $156 of additional TCOC per member episode per month prior to implementation of dose rounding.
  • Dose rounding resulted in a TCOC reduction of approximately $100 per member episode per month for episodes with B+B administrations in the OCM.
  • ), and in administrations where drug waste was greater than 10% of the total dose.

ASCO 2023: Integra Connect to Showcase how its Technology and Real-World Data are Helping Deliver on the Promise of Value-based, Precision Oncology

Retrieved on: 
Friday, May 26, 2023
EOL, Abstract, Oncology Care Model, Maintenance, OCM, Marie Cassidy, Survival, Water Quality Initiative, Cancer, Lung cancer, Thermo Fisher Scientific, NSCLC, Immunotherapy, Quality, ASCO, Organization, BD, Community, Health care, American Society of Clinical Oncology, MD, Patient, Machine learning, Medicine, Annual general meeting, UPMC, ICU, BRCA, Poster, ED, Ovarian cancer, Death, Health, Society, III, Prostate cancer, SACT, Pharmaceutical industry, Medical device, Medical imaging, Nursing, Research

WEST PALM BEACH, Fla., May 26, 2023 /PRNewswire/ -- Integra Connect, LLC., the leading provider of value-based, precision medicine solutions and services for specialty care, today announced that results from 12 studies will be highlighted during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6. The studies, conducted by Integra Connect and leading organizations such as Thermo Fisher Scientific, will highlight how:

Key Points: 
  • Leading provider organizations and Integra Connect evaluated data from oncology value-based care programs and uncovered trends on to how to best support oncology patients, from bedside care to treatment.
  • Integra Connect's robust real-world, de-identified oncology data set was utilized by leading life sciences organizations for five studies that were accepted as online abstracts by ASCO.
  • This research shows broad implications for the use of de-identified real-world data to identify treatment gaps and improve patient care.
  • Results from those studies will be available via online abstract:
    For more insights on Integra Connect's research and presence at ASCO 2023, please go here .